Scientists investigate rare breast cancer subtype to improve future care
NCT ID NCT07613151
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study looks back at medical records of 250 people with a rare type of breast cancer called apocrine lobular carcinoma. Researchers want to understand how this cancer behaves, what treatments patients received, and how they did over time. No new treatments are tested — the goal is to gather information to help doctors better recognize and manage this rare disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE LOBULAR CARCINOMA OF THE BREAST are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Veneto Institute of Oncology
RECRUITINGPadova, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a scan replace surgery for breast cancer staging?
- New tests could predict if breast cancer therapy is working
- New registry hopes to unlock secrets of rare breast cancer
- Can Pre-Surgery hormone therapy help lobular breast cancer patients?
- New scan may better detect Hard-to-Find breast cancer spread
- New radiation method may boost immune attack on tumors